Suppr超能文献

纳米颗粒是否为诊断远端气腔疾病提供了新的机会?

Do nanoparticles provide a new opportunity for diagnosis of distal airspace disease?

机构信息

Division of Ergonomics and Aerosol Technology (EAT), Department of Design Sciences; NanoLund, Lund University, Lund, Sweden.

Faculty of Civil and Environmental Engineering, Technion, Haifa, Israel.

出版信息

Int J Nanomedicine. 2016 Dec 19;12:41-51. doi: 10.2147/IJN.S121369. eCollection 2017.

Abstract

There is a need for efficient techniques to assess abnormalities in the peripheral regions of the lungs, for example, for diagnosis of pulmonary emphysema. Considerable scientific efforts have been directed toward measuring lung morphology by studying recovery of inhaled micron-sized aerosol particles (0.4-1.5 µm). In contrast, it is suggested that the recovery of inhaled airborne nanoparticles may be more useful for diagnosis. The objective of this work is to provide a theoretical background for the use of nanoparticles in measuring lung morphology and to assess their applicability based on a review of the literature. Using nanoparticles for studying distal airspace dimensions is shown to have several advantages over other aerosol-based methods. 1) Nanoparticles deposit almost exclusively by diffusion, which allows a simpler breathing maneuver with minor artifacts from particle losses in the oropharyngeal and upper airways. 2) A higher breathing flow rate can be utilized, making it possible to rapidly inhale from residual volume to total lung capacity (TLC), thereby eliminating the need to determine the TLC before measurement. 3) Recent studies indicate better penetration of nanoparticles than micron-sized particles into poorly ventilated and diseased regions of the lungs; thus, a stronger signal from the abnormal parts is expected. 4) Changes in airspace dimensions have a larger impact on the recovery of nanoparticles. Compared to current diagnostic techniques with high specificity for morphometric changes of the lungs, computed tomography and magnetic resonance imaging with hyperpolarized gases, an aerosol-based method is likely to be less time consuming, considerably cheaper, simpler to use, and easier to interpret (providing a single value rather than an image that has to be analyzed). Compared to diagnosis by carbon monoxide (), the uptake of nanoparticles in the lung is not affected by blood flow, hemoglobin concentration or alterations of the alveolar membranes, but relies only on lung morphology.

摘要

需要有效的技术来评估肺部外周区域的异常,例如用于诊断肺气肿。人们已经投入了大量的科学努力来通过研究吸入的微米级气溶胶颗粒(0.4-1.5 µm)的恢复来测量肺形态。相比之下,有人认为吸入的空气传播纳米颗粒的恢复可能对诊断更有用。这项工作的目的是为使用纳米颗粒测量肺形态提供理论基础,并根据文献综述评估它们的适用性。与其他基于气溶胶的方法相比,使用纳米颗粒研究远端气腔尺寸具有几个优势。1)纳米颗粒几乎仅通过扩散沉积,这使得呼吸操作更简单,并且由于口咽和上呼吸道中颗粒损失而产生的伪影较小。2)可以利用更高的呼吸流速,从而可以从残气量快速吸入到总肺活量(TLC),从而无需在测量前确定 TLC。3)最近的研究表明,纳米颗粒比微米级颗粒更能穿透肺部通气不良和患病区域;因此,预计异常部位的信号会更强。4)气腔尺寸的变化对纳米颗粒的恢复有更大的影响。与具有高特异性的肺部形态计量变化的当前诊断技术(如计算机断层扫描和磁共振成像与超极化气体)相比,基于气溶胶的方法可能更耗时、更便宜、更简单易用、更易于解释(提供单个值而不是必须分析的图像)。与一氧化碳()诊断相比,纳米颗粒在肺部的摄取不受血流、血红蛋白浓度或肺泡膜改变的影响,而仅依赖于肺形态。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f030/5191892/3bf0fefb65ed/ijn-12-041Fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验